Work

Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma

Year: 2015

Type: article

Study design: Clinical Trial

Abstract: Systemic anaplastic large cell lymphoma (ALCL) is a subtype of peripheral T-cell lymphoma. It is divided into cases with and without translocation of the anaplastic lymphoma kinase gene ( ALK ), which most commonly involves chromosomes 2 and 5 and leads to ALK overexpression. Most patients with ALK

Source: Haematologica

DOI: 10.3324/haematol.2015.131151

Authors: K. Dunleavy, S. Pittaluga, M. Shovlin, M. Roschewski, C. Lai, S. M. Steinberg, E. S. Jaffe, W. H. Wilson

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funder: National Institutes of Health

OpenAlex ID: W1853538644

FWCI: 2.304

Cites: 15

Cited by: 25

Related to: 10